First Horizon Corporation’s Cidara Therapeutics CDTX Stock Holding History

First Horizon Corporation’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-153	Closed	-$33.8K	–	1475
2025 Q4	$33.8K	Sell	153 -91	-37%	-$14.7K	﹤0.01%	799
2025 Q3	$23.4K	Buy	+244	New	+$15.6K	﹤0.01%	814

First Horizon Corporation's CDTX Position: Q1 2026 in Review

First Horizon Corporation sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 153 shares — an estimated $33.8K sold.

First Horizon Corporation first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $33.8K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

First Horizon Corporation reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
First Horizon Corporation sold 153 Cidara Therapeutics shares in Q1 2026, an estimated $33.8K.
First Horizon Corporation first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
First Horizon Corporation's Cidara Therapeutics position peaked at $33.8K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on First Horizon Corporation's 13F filing for Q1 2026, filed 30 Apr 2026.